Published in Cathet Cardiovasc Diagn on May 01, 1998
Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy. Curr Cardiol Rev (2015) 0.75
Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation (1997) 4.09
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol (1998) 3.03
Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction. Eur J Echocardiogr (2000) 1.74
Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography. Circulation (1998) 1.54
[The therapy of coronary heart disease. The current aspects]. Dtsch Med Wochenschr (1991) 1.39
[The recanalization of the chronically occluded infarct vessel in single-vessel coronary disease. The reduction of cardiac events in long-term clinical follow-up]. Dtsch Med Wochenschr (1995) 1.39
Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Clin Res Cardiol (2007) 1.32
Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis. Circulation (1999) 1.18
Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases. J Neurol Neurosurg Psychiatry (2001) 1.14
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). Eur Heart J (1999) 1.10
In vivo evaluation of the Lillehei-Kaster heart valve prosthesis. Ann Thorac Surg (1976) 1.07
Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy. Thorac Cardiovasc Surg (1999) 1.01
[Diagnostic and prognostic value of endomyocardial biopsy in patients with congestive cardiomyopathy (author's transl)]rdiomyopathy(author. Dtsch Med Wochenschr (1975) 1.00
Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. Eur Respir J (2009) 0.99
Two-dimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: a study in athletes and in patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging (2010) 0.96
Improvement of coronary vasodilatation capacity through single LDL apheresis. Atherosclerosis (1998) 0.95
[Stereospecific synthesis of two 9,11,12,13, 13a, 14-hexahydrodibenzo(f,h)pyrrolo(1,2-beta)isoquinolines (author's transl)]. Helv Chim Acta (1976) 0.93
[Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure]. Dtsch Med Wochenschr (2007) 0.92
[Analysis of inter- and intraventricular asynchrony by tissue Doppler echocardiography]. Z Kardiol (2003) 0.91
Results of heart transplantation in patients with preexisting malignancies. Am J Cardiol (1997) 0.89
Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area. Catheter Cardiovasc Interv (1999) 0.87
Diagnostic superiority of a combined assessment of the systolic and early diastolic mitral annular velocities by tissue Doppler imaging for the differentiation of restrictive cardiomyopathy from constrictive pericarditis. Clin Res Cardiol (2010) 0.86
Echo-guided percutaneous coil embolization of a symptomatic massive metastasis of a renal cell carcinoma in the right ventricular outflow tract. Eur J Echocardiogr (2008) 0.85
[Improved coronary vasodilator capacity by drug lipid lowering therapy in patients in the early stage of coronary atherosclerosis with reduced coronary reserves and moderate LDL hypercholesteremia]. Z Kardiol (1998) 0.84
Alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Cardiol Rev (2001) 0.83
[Percutaneous mitral valvulotomy with the Inoue balloon in over 65-year-old patients--acute results and short-term follow-up in comparison with younger patients]. Z Kardiol (1995) 0.83
[Doppler echocardiography description of diastolic function disorder in terminal renal failure--new characterization of uremic cardiomyopathy]. Z Kardiol (1990) 0.83
[Obstructive myocardiopathy]. Z Kreislaufforsch (1971) 0.82
[Metastasizing round-cell sarcoma of the right atrium]. Dtsch Med Wochenschr (1991) 0.82
[Congestive cardiomyopathy]. Med Welt (1973) 0.82
[Catheter treatment of hypertrophic obstructive cardiomyopathy]. Dtsch Med Wochenschr (1996) 0.81
Aortic valve surgery following previous coronary artery bypass grafting. Impact of calcification and leaflet movement. Int J Cardiol (1998) 0.81
Regional myocardial free fatty acid extraction in normal and ischemic myocardium. Circulation (1988) 0.81
Valsartan versus ACE inhibition after bare metal stent implantation--results of the VALVACE trial. Int J Cardiol (2005) 0.80
Right atrial hemangioma in modern cardiac imaging. Clin Res Cardiol (2006) 0.80
Influence of heart rate on systolic time intervals: effects of atrial pacing versus dynamic exercise. Clin Cardiol (1981) 0.80
Radiation protection during cardiac catherization: development of an improved lead apron for periinterventional echocardiography. Minerva Cardioangiol (2015) 0.80
[Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy]. Z Kardiol (2003) 0.79
[Diagnosis and differential therapy of mitral stenosis]. Herz (1998) 0.79
[Quantitative measurement of force and velocity of force development in the apex cardiogram. A new technic]. Z Gesamte Exp Med (1968) 0.79
[Circular dissection of the ascending aorta with intimo-intimal invagination. CT diagnosis of a rare form of aortic dissection]. Radiologe (1996) 0.79
[Steady state kinetics of isosorbide-5-mononitrate in patients with coronary disease]. Med Welt (1981) 0.78
Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients. Int J Cardiovasc Imaging (2014) 0.78
Predictors of unsuccessful outcome after percutaneous mitral valvulotomy including a new echocardiographic scoring system. J Heart Valve Dis (1996) 0.78
Fatty acid uptake in normal human myocardium. Circ Res (1991) 0.78
Converting enzyme inhibition in coronary artery disease: a randomized, placebo-controlled trial with benazepril. J Cardiovasc Pharmacol (1991) 0.78
[Secondary aldosteronism following surgery using the heart-lung machine and its regulation with Aldactone]. Anaesthesist (1965) 0.78
Cardiac catheterization in Germany. Diffusion and utilization from 1984 to 1996. Int J Technol Assess Health Care (1999) 0.78
Outflow acceleration assessed by continuous-wave doppler echocardiography in left ventricular hypertrophy: an analysis of 103 consecutive cases. Cardiology (1998) 0.78
[4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment]. Herz (1985) 0.77
The prevalence of the prothrombin 20210 G-->A mutation is not increased in angiographically confirmed coronary artery disease. Thromb Haemost (1999) 0.77
Left ventricular mass and oxygen uptake in top handball athletes. Int J Sports Med (2012) 0.77
[Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy ]. Dtsch Med Wochenschr (2008) 0.77
Pre B cell leukaemia in the rat. Adv Exp Med Biol (1982) 0.77
Long-term oral antiarrhythmic therapy with aprindine (AC 1802). Acta Cardiol (1974) 0.77
Ultrasound examination of stenotic mitral valves: an in vitro study. Am J Card Imaging (1996) 0.77
Pathomorphological characteristics of resected mitral valves after unsuccessful valvuloplasty. J Cardiovasc Surg (Torino) (1996) 0.76
[Acute aortic dissection (Stanford A) with pericardial tamponade--extension of the dissection after emergency pericardial puncture]. Z Kardiol (1998) 0.76
[One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy]. Dtsch Med Wochenschr (2001) 0.76
[Congenital coronary artery aneurysm: a rare cause of acute myocardial infarct]. Z Kardiol (1996) 0.76
Blood pressure self-measurement in upper arm and in wrist for treatment control of arterial hypertension compared to ABPM. Z Kardiol (1996) 0.76
[Constrictive pericarditis or restrictive cardiomyopathy? Echocardiographic tissue Doppler analysis]. Dtsch Med Wochenschr (2008) 0.75
[Non-invasive effects of cigarette smoking on left ventricular function at rest and with exercise in normal individuals (author's transl)]. Z Kardiol (1979) 0.75
[Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography]. Z Kardiol (1998) 0.75
The influence of beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity on local wall motion abnormalities in patients with coronary heart disease. Br J Clin Pharmacol (1982) 0.75
[Ergotamine-induced heart valve fibrosis]. Dtsch Med Wochenschr (1993) 0.75
The management of hypertrophic cardiomyopathy. N Engl J Med (1997) 0.75
Acute and long-term results after TASH. Eur Heart J (2000) 0.75
[Arteriosclerosis--a Chlamydia pneumoniae infection?]. Dtsch Med Wochenschr (1998) 0.75
[Follow-up studies on patients with a non-obstructive form of idiopathic hypertrophic myocardiopathy]. Verh Dtsch Ges Inn Med (1971) 0.75
[Bundle of His electrography in the Lown-Ganong-Levine syndrome]. Verh Dtsch Ges Inn Med (1974) 0.75
[Continuous measurement of the coronary venous oxygen tension to test coronary active substances]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1969) 0.75
[1-Year-results of anuloplastisy (Carpentier-technic) in 7 patients (author's transl)]. Thoraxchir Vask Chir (1975) 0.75
[Clinical experiences with a new orally effective antiarrhythmic agent (Aprindin)]. Z Kardiol (1974) 0.75
[Comparison of bipolar precordial leads with conventional leads in ergometric studies]. Med Welt (1975) 0.75
[Effect of the antiarrhythmic agent Aprindin (AC 1802) on the conductive of excitation and on the spontaneous automatics of the human heart]. Z Kardiol (1974) 0.75
[Proceedings: Function of the left ventricle during dynamic load and after left ventricular angiography]. Z Kardiol (1974) 0.75
[Type and incidence of side-effects during the treatment of arrhythmia with aprindin (AC 1802)]. Verh Dtsch Ges Inn Med (1974) 0.75
[Mitral valve insufficiency following mitral valve prosthesis]. Z Kreislaufforsch (1971) 0.75
Action of antiarrhythmic drugs on His bundle electrogram and sinus node function. Acta Cardiol (1974) 0.75
[Origin of the apical beat and significance of systolic changes in the apexcardiogram]. Z Kreislaufforsch (1971) 0.75
[Relations between left ventricular end-diastolic pressure and pulmonary artery pressure in rest and under loading by simultaneous measurements]. Med Welt (1975) 0.75
[Blood flow measurement in the subclavian artery before and after application of a Blalock anastomosis]. Zentralbl Chir (1967) 0.75
[The ventricular volume in cardiac insufficiency]. Verh Dtsch Ges Kreislaufforsch (1968) 0.75
[Clinical importance and diagnosis of the LGL-syndrome]. Med Welt (1974) 0.75
[Left ventricular Doppler ultrasonics cardiogram]. Z Kreislaufforsch (1971) 0.75